Randomized Trial Comparison of Ototoxicity Monitoring Programs

NCT02099786 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

47

Enrollment

FED

Sponsor class

Conditions

Cisplatin Ototoxicity
Hearing Loss

Interventions

OTHER: COMP-VA
OTHER: Standard of care

Sponsor

VA Office of Research and Development